Two cases of neural tube defects with dolutegravir use at conception in south Brazil
dc.contributor.author | Kreitchmann, Regis | pt_BR |
dc.contributor.author | Oliveira, Fernando Rocha de | pt_BR |
dc.contributor.author | Sprinz, Eduardo | pt_BR |
dc.date.accessioned | 2022-04-07T04:48:29Z | pt_BR |
dc.date.issued | 2021 | pt_BR |
dc.identifier.issn | 1413-8670 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/10183/236731 | pt_BR |
dc.description.abstract | Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neural tube defects (NTD) in Botswana, Africa. Herein we describe two cases of NTD in women who conceived while taking DTG as part of their antiretroviral treatment in the city of Porto Alegre, Brazil. | en |
dc.format.mimetype | application/pdf | pt_BR |
dc.language.iso | eng | pt_BR |
dc.relation.ispartof | The Brazilian journal of infectious diseases. Salvador. Vol. 25, no. 2 (Mar./Apr. 2021), 101572, 4 p. | pt_BR |
dc.rights | Open Access | en |
dc.subject | COVID-19 | en |
dc.subject | HIV | pt_BR |
dc.subject | Gravidez | pt_BR |
dc.subject | Neural tube defects | en |
dc.subject | Pregnancy | en |
dc.subject | Defeitos do tubo neural | pt_BR |
dc.subject | Porto Alegre (RS) | pt_BR |
dc.subject | Dolutegravir | en |
dc.title | Two cases of neural tube defects with dolutegravir use at conception in south Brazil | pt_BR |
dc.type | Artigo de periódico | pt_BR |
dc.identifier.nrb | 001137454 | pt_BR |
dc.type.origin | Nacional | pt_BR |
Este item está licenciado na Creative Commons License
![](/themes/Mirage2Novo//images/lume/cc.png)
-
Artigos de Periódicos (39541)Ciências da Saúde (10601)